Chief Executive Officer
Avg Cost/Share
$1.20
Shares
1,522
Total Value
$1,825.18
Owned After
338,181
SEC Form 4
Chief Executive Officer
Avg Cost/Share
$1.23
Shares
7,329
Total Value
$9,014.67
Owned After
338,181
SEC Form 4
Chief Executive Officer
Avg Cost/Share
$7.48
Shares
1,708
Total Value
$12,775.84
Owned After
338,181
SEC Form 4
Head, Research & Autoimmunity
Avg Cost/Share
$11.54
Shares
1,487
Total Value
$17,158.20
Owned After
338,181
SEC Form 4
Head, Research & Autoimmunity
Avg Cost/Share
$7.58
Shares
1,570
Total Value
$11,893.22
Owned After
338,181
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| Harler Mary Beth | IGMS | Chief Executive Officer | Jun 16, 2025 | Sell | $1.20 | 1,522 | $1,825.18 | 338,181 | |
| Harler Mary Beth | IGMS | Chief Executive Officer | Mar 14, 2025 | Sell | $1.23 | 7,329 | $9,014.67 | 338,181 | |
| Harler Mary Beth | IGMS | Chief Executive Officer | Dec 16, 2024 | Sell | $7.48 | 1,708 | $12,775.84 | 338,181 | |
| Harler Mary Beth | IGMS | Head, Research & Autoimmunity | Sep 13, 2024 | Sell | $11.54 | 1,487 | $17,158.20 | 338,181 | |
| Harler Mary Beth | IGMS | Head, Research & Autoimmunity | Jun 14, 2024 | Sell | $7.58 | 1,570 | $11,893.22 | 338,181 |